Abstractα-Glucosidase (EC 3.2.1.3) is a lysosomal enzyme that hydrolyses α-1,4- and α-1,6-linkages of glycogen to produce free glucose. A deficiency in α-glucosidase activity results in glycogen storage disorder type II (GSD II), also called Pompe disease. Here, d-glucose was shown to be a competitive inhibitor of α-glucosidase and when added to culture medium at 6.0g/L increased the production of this protein by CHO-K1 expression cells and stabilised the enzyme activity. d-Glucose also prevented α-glucosidase aggregation/precipitation and increased protein yield in a modified purification scheme. In fibroblast cells, from adult-onset GSD II patients, d-glucose increased the residual level of α-glucosidase activity, suggesting that a struct...
Tay Sachs and Gaucher diseases are lysosomal storage disorders that are caused by deficiencies in t...
The development of small molecule activity-based probes (ABPs) is an evolving and powerful area of c...
Glycogen storage disease type II (GSDII) or Pompe disease is an autosomal recessive disorder caused ...
Abstractα-Glucosidase (EC 3.2.1.3) is a lysosomal enzyme that hydrolyses α-1,4- and α-1,6-linkages o...
alpha-Glucosidase (EC 3.2.1.3) is a lysosomal enzyme that hydrolyses alpha-1,4- and alpha-1,6-linkag...
textabstractPompe’s disease is an inherited metabolic illness, caused by an inherited deficiency of...
α-Glucosidase inhibitors are potential therapeutics for the treatment of diabetes, viral infections,...
Glycogen storage disease type II (GSD II/glycogenosis type II/Pompe's disease/acid maltase deficienc...
Pompe disease (type II glycogen storage disease) is an autosomal recessive disorder caused by a defi...
The glycosylhydrolase glucocerebrosidase (GBA) cleaves the β-D-glucose moiety from one of the simple...
The lysosomal storage disorders are genetic diseases arising from a deficiency of a lysosomal prote...
Michael BeckChildren’s Hospital, University of Mainz, Mainz, GermanyAbstract: Pompe diseas...
We investigated the use of pharmacological chaperones for the therapy of Pompe disease, a metabolic ...
We investigated the use of pharmacological chaperones for the therapy of Pompe disease, a metabolic ...
β-Glucocerebrosidase is a lysosomal enzyme responsible for the degradation of glucosylceramide, a gl...
Tay Sachs and Gaucher diseases are lysosomal storage disorders that are caused by deficiencies in t...
The development of small molecule activity-based probes (ABPs) is an evolving and powerful area of c...
Glycogen storage disease type II (GSDII) or Pompe disease is an autosomal recessive disorder caused ...
Abstractα-Glucosidase (EC 3.2.1.3) is a lysosomal enzyme that hydrolyses α-1,4- and α-1,6-linkages o...
alpha-Glucosidase (EC 3.2.1.3) is a lysosomal enzyme that hydrolyses alpha-1,4- and alpha-1,6-linkag...
textabstractPompe’s disease is an inherited metabolic illness, caused by an inherited deficiency of...
α-Glucosidase inhibitors are potential therapeutics for the treatment of diabetes, viral infections,...
Glycogen storage disease type II (GSD II/glycogenosis type II/Pompe's disease/acid maltase deficienc...
Pompe disease (type II glycogen storage disease) is an autosomal recessive disorder caused by a defi...
The glycosylhydrolase glucocerebrosidase (GBA) cleaves the β-D-glucose moiety from one of the simple...
The lysosomal storage disorders are genetic diseases arising from a deficiency of a lysosomal prote...
Michael BeckChildren’s Hospital, University of Mainz, Mainz, GermanyAbstract: Pompe diseas...
We investigated the use of pharmacological chaperones for the therapy of Pompe disease, a metabolic ...
We investigated the use of pharmacological chaperones for the therapy of Pompe disease, a metabolic ...
β-Glucocerebrosidase is a lysosomal enzyme responsible for the degradation of glucosylceramide, a gl...
Tay Sachs and Gaucher diseases are lysosomal storage disorders that are caused by deficiencies in t...
The development of small molecule activity-based probes (ABPs) is an evolving and powerful area of c...
Glycogen storage disease type II (GSDII) or Pompe disease is an autosomal recessive disorder caused ...